ライフサイエンスコーパス: right ventricular dysfunction

1 th commonly available noninvasive indices of right ventricular dysfunction.

2 of extracorporeal support for patients with right ventricular dysfunction.

3 ion was 31%, and 60% had moderate or greater right ventricular dysfunction.

4 ents with pulmonary embolism and evidence of right ventricular dysfunction.

5 n were compared in patients with and without right ventricular dysfunction.

6 graphic indicators of worse hemodynamics and right ventricular dysfunction.

7 in most), and only 5.1% of patients had mild right ventricular dysfunction.

8 the pulmonary microvasculature culminated in right ventricular dysfunction.

9 erely elevated pulmonary blood pressures and right ventricular dysfunction.

10 olism who are hemodynamically stable without right ventricular dysfunction.

11 ive to resistive, load and may contribute to right ventricular dysfunction.

12 All had significant right ventricular dysfunction.

13 rited cardiomyopathy characterized by VT and right ventricular dysfunction.

14 ight ventricle, ventricular arrhythmias, and right ventricular dysfunction.

15 atients with respiratory failure, shock, and right ventricular dysfunction.

16 t, and thus is indicative of the severity of right ventricular dysfunction.

17 ysfunction and heart failure, in addition to right ventricular dysfunction.

18 arction is limited by concerns for potential right ventricular dysfunction.

19 ng normothermic blood had less postoperative right ventricular dysfunction (10%) than did patients re

20 ess inotrope use (71% versus 84%, P:=0.002), right ventricular dysfunction (23% versus 41%, P:=0.001)

21 xtension request for an exception status was right ventricular dysfunction (24%).

22 n heavy chain 6, in 2 patients who developed right ventricular dysfunction 3 to 11 years postoperativ

23 fications (16.3% versus 27.4%; P=0.002), and right ventricular dysfunction (42.1% versus 57.9%; P=0.0

24 m derangements in lung structure or residual right ventricular dysfunction affecting cardiac output.

25 patients with higher-risk characteristics or right ventricular dysfunction and a stricter set of crit

26 ormed before the development of irreversible right ventricular dysfunction and an increased risk of v

27 Right ventricular dysfunction and congestive states may

28 are common in many lung diseases leading to right ventricular dysfunction and death.

29 Older age, right ventricular dysfunction and diastolic dysfunction

30 y was to further explore the significance of right ventricular dysfunction and investigate potential

31 rtery may drive this pathology by increasing right ventricular dysfunction and lung vascular remodeli

32 oscillatory ventilation+15, 15 patients had right ventricular dysfunction and nine had right ventric

33 Presence of significant right ventricular dysfunction and number of T-wave inver

34 cular diastolic dysfunction grade II or III, right ventricular dysfunction and pericardial effusions.

35 ted plasma levels of MBG are associated with right ventricular dysfunction and predict worse long-ter

36 In the Cox proportional hazards model, right ventricular dysfunction and pulmonary hypertension

37 icular diameter ratio on CT as indicators of right ventricular dysfunction and reported that recurren

38 Preoperative echocardiography, in particular right ventricular dysfunction and restrictive left ventr

39 anagement of pulmonary hypertension to avoid right ventricular dysfunction and to maintain cardiac ou

40 an inherited cardiomyopathy characterized by right ventricular dysfunction and ventricular arrhythmia

41 an inherited cardiomyopathy characterized by right ventricular dysfunction and ventricular arrhythmia

42 is a rare inherited disease characterized by right-ventricular dysfunction and ventricular arrhythmia

43 cardial inflammation, myocardial infarction, right ventricular dysfunction, and arrhythmias.

44 New York Heart Association functional class, right ventricular dysfunction, and atrial fibrillation (

45 right ventricular systolic pressure, severe right ventricular dysfunction, and exaggerated vascular

46 /kg, left ventricular ejection fraction<50%, right ventricular dysfunction, and heart rate/respirator

47 gical abnormalities, markers of end-organ or right ventricular dysfunction, and lack of inotropic sup

48 onary arterial systolic pressure >40 mm Hg), right ventricular dysfunction, and mitral regurgitation

49 ercise intolerance, atrial tachyarrhythmias, right ventricular dysfunction, and pulmonary hypertensio

50 with versus without PH, with versus without right ventricular dysfunction, and with versus without l

51 y pressure signaling analysis have uncovered right ventricular dysfunction as a mediator of heart fai

52 of 938 patients with pulmonary embolism had right ventricular dysfunction, as assessed by measuremen

53 , 2.96; 95% confidence interval, 1.59-5.49), right ventricular dysfunction, as evidenced by fractiona

54 Right ventricular dysfunction, but not functional RV hyp

55 Increased LGE burden and right ventricular dysfunction can identify LGE+ patients

56 pulmonary hypertension, may result in severe right ventricular dysfunction caused by lung disease, al

57 eft atrial myopathy, pulmonary hypertension, right ventricular dysfunction, chronotropic incompetence

58 Imaging, Cardiac MRI, Aortic Regurgitation, Right Ventricular Dysfunction Clinical trial registratio

59 embolism and concomitant moderate to severe right ventricular dysfunction despite preserved systemic

60 ing can be useful in diagnosing and treating right ventricular dysfunction, especially when associate

61 stenosis (AS), but the prognostic impact of right ventricular dysfunction has not been well studied.

62 goal-directed echocardiography in diagnosing right ventricular dysfunction in acute pulmonary embolis

63 intensivists' interpretations for evaluating right ventricular dysfunction in acute pulmonary embolis

64 increased pulmonary vascular resistance and right ventricular dysfunction in both HF phenotypes.

65 olic dysfunction in eight (57%) patients and right ventricular dysfunction in four (29%) patients.

66 rent understanding of the pathophysiology of right ventricular dysfunction in heart failure with pres

67 Circulating FGF-23 is thus a biomarker of right ventricular dysfunction in HFrEF patients regardle

68 There is no biomarker reflecting right ventricular dysfunction in HFrEF patients used in

69 inants of hypoplastic left heart with latent right ventricular dysfunction in individuals with a Font

70 The REDEFINE trial (Right Ventricular Dysfunction in Tetralogy of Fallot: In

71 Echocardiography revealed similar degrees of right ventricular dysfunction in the 2 groups, whereas a

72 y elevated pulmonary vascular resistance and right ventricular dysfunction in the absence of pulmonar

73 versus 61+/-7 and 61+/-7 mm, P<0.0001), more right ventricular dysfunction, increased epicardial fat

74 Right ventricular dysfunction is a hallmark of advanced

75 Right ventricular dysfunction is a powerful determinant

76 Right ventricular dysfunction is an important and indepe

77 In patients with pulmonary embolism, right ventricular dysfunction is associated with early m

78 of tricuspid regurgitation in the setting of right ventricular dysfunction is associated with poor pr

79 pulmonary embolism using imaging presence of right ventricular dysfunction is essential for triage; h

80 pulmonary arterial pressure and resistance, right ventricular dysfunction, left ventricular compress

81 We have learned that right ventricular dysfunction may be a predictor of surv

82 demonstrated increased pulmonary pressures, right ventricular dysfunction (mid strain 16+/-5% versus

83 pressure, left ventricle ejection fraction, right ventricular dysfunction, mitral regurgitation, lef

84 Right ventricular dysfunction, moderate-severe tricuspid

85 osis and 1 with pulmonary regurgitation), or right ventricular dysfunction (n=2).

86 athology and epidemiology of Group 3 PH, the right ventricular dysfunction observed in this populatio

87 ggesting that AVR should be discussed before right ventricular dysfunction occurs in severe AS.

88 Eligible patients had right ventricular dysfunction on echocardiography or com

89 ort class, use of multiple inotropes, severe right ventricular dysfunction on echocardiography, ratio

90 Right ventricular dysfunction on initial echocardiogram

91 Right-ventricular dysfunction on echocardiography and hi

92 o four hierarchical groups: normal function, right ventricular dysfunction only (RV(dys)), left ventr

93 anced therapies being options for those with right ventricular dysfunction or unstable hemodynamics.

94 tion (P<0.01), pulmonary hypertension and/or right ventricular dysfunction (P=0.01), and regional wal

95 ion (P=0.03), mitral valve surgery (P=0.02), right ventricular dysfunction (P=0.03), and higher mean

96 normal pressure profile to the low flow with right ventricular dysfunction profile.

97 slightly higher in patients with HF-PH with right ventricular dysfunction, pulmonary vascular remode

98 Advanced right ventricular dysfunction reduces the likelihood of

99 61% had left atrial dysfunction and systemic right ventricular dysfunction, respectively; while 43% a

100 n of LGE (14+/-11 versus 5+/-5%, P<0.01) and right ventricular dysfunction (right ventricular EF 45+/

101 nical ventilation, nine patients presented a right ventricular dysfunction (right ventricular end-dia

102 function, increased pulmonary pressures, and right ventricular dysfunction (right ventricular mid str

103 Right ventricular dysfunction (RVD) is common in patient

104 Right ventricular dysfunction (RVD) is the leading cause

105 PH and direct cardiac injury beget right ventricular dysfunction (RVD) occurrence, which ha

106 Scarce data exist on patients with right ventricular dysfunction (RVD) or pulmonary hyperte

107 Right ventricular dysfunction (RVD) significantly affect

108 nary artery vasculature damage (Stage 3) and right ventricular dysfunction (Stage 4).

109 pid regurgitation (stage 3), and significant right ventricular dysfunction (stage 4).

110 Ms A, a 60-year-old woman with acute PE and right ventricular dysfunction (submassive PE), illustrat

111 increased pulmonary vascular resistance, and right ventricular dysfunction that promotes heart failur

112 g those who were hemodynamically stable with right ventricular dysfunction, thrombolytic therapy was

113 h EF 50% and no significant valve disease or right ventricular dysfunction, undergoing exercise stres

114 Screening for right ventricular dysfunction using goal-directed echoca

115 T-proBNP value was elevated (910 pg/mL), and right ventricular dysfunction was moderate/severe in 55%

116 No right ventricular dysfunction was observed.

117 pulmonary vascular resistance (PVR) >4 WU or right ventricular dysfunction were excluded.

118 ormalities and pulmonary hypertension and/or right ventricular dysfunction, were independently associ

119 embolic pulmonary hypertension (CTEPH) cause right ventricular dysfunction, which can impact other so

120 ined as echocardiographic evidence of severe right ventricular dysfunction with New York Heart Associ